Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Femasys Inc., 3 years.
Femasys Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 5, 2026 | Bicycle Therapeutics plc | Open-market sale | −3,416 | $6.46 | $22,067 |
| Jan 2, 2026 | Bicycle Therapeutics plc | Grant or award | +50,000 | — | — |
| Jan 2, 2026 | Bicycle Therapeutics plc | Open-market sale | −3,244 | $6.80 | $22,059 |
| Oct 3, 2025 | Bicycle Therapeutics plc | Open-market sale | −978 | $8.41 | $8,225 |
| Oct 2, 2025 | Bicycle Therapeutics plc | Open-market sale | −1,147 | $8.40 | $9,635 |
| Jul 3, 2025 | Bicycle Therapeutics plc | Open-market sale | −966 | $7.44 | $7,187 |
| Jul 2, 2025 | Bicycle Therapeutics plc | Open-market sale | −1,149 | $7.09 | $8,146 |
| Apr 3, 2025 | Bicycle Therapeutics plc | Open-market sale | −1,038 | $7.48 | $7,764 |
| Apr 2, 2025 | Bicycle Therapeutics plc | Open-market sale | −1,133 | $8.02 | $9,087 |
| Jan 3, 2025 | Bicycle Therapeutics plc | Open-market sale | −936 | $14.75 | $13,806 |
| Jan 2, 2025 | Bicycle Therapeutics plc | Grant or award | +35,000 | — | — |
| Jan 2, 2025 | Bicycle Therapeutics plc | Open-market sale | −4,578 | $14.09 | $64,504 |
| Oct 3, 2024 | Bicycle Therapeutics plc | Open-market sale | −972 | $22.26 | $21,637 |
| Jul 3, 2024 | Bicycle Therapeutics plc | Open-market sale | −967 | $19.64 | $18,992 |
| Apr 3, 2024 | Bicycle Therapeutics plc | Open-market sale | −955 | $23.81 | $22,739 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.